Parvovirus B19 infection in Tunisian patients with sickle-cell anemia and acute erythroblastopenia
<p>Abstract</p> <p>Background</p> <p>Human parvovirus B19 is the etiologic agent of erythema infectiosum in children. It is also associated with other clinical manifestations in different target groups. Patients with chronic hemolytic anemia are at high risk of developi...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2007-10-01
|
| Series: | BMC Infectious Diseases |
| Online Access: | http://www.biomedcentral.com/1471-2334/7/123 |
| _version_ | 1811267177631711232 |
|---|---|
| author | Zili Mohamed Karoui Mongi Bejaoui Mohamed Oussaief Lassad Regaya Faouzi Khelifa Ridha |
| author_facet | Zili Mohamed Karoui Mongi Bejaoui Mohamed Oussaief Lassad Regaya Faouzi Khelifa Ridha |
| author_sort | Zili Mohamed |
| collection | DOAJ |
| description | <p>Abstract</p> <p>Background</p> <p>Human parvovirus B19 is the etiologic agent of erythema infectiosum in children. It is also associated with other clinical manifestations in different target groups. Patients with chronic hemolytic anemia are at high risk of developing acute erythroblastopenia following infection by the virus. They usually become highly viremic and pose an increased risk of virus transmission. Close monitoring of such high risk groups is required for epidemiologic surveillance and disease prevention activities. Here we report a molecular epidemiological study on B19 virus infection in Tunisian patients with chronic hemolytic anemia.</p> <p>Methods</p> <p>This study was conducted on 92 young chronic hemolytic anemia patients who attended the same ward at the National Bone Marrow Transplantation Center of Tunis and 46 controls from a different hospital. Screening for IgM and IgG anti-B19 antibodies was performed using commercially available enzyme immunoassays and B19 DNA was detected by nested PCR in the overlapping <it>VP1/VP2 </it>region. DNA was sequenced using dideoxy-terminator cycle sequencing technology.</p> <p>Results</p> <p>Anti-parvovirus B19 IgG antibodies were detected in 26 of 46 sickle-cell anemia patients, 18 of 46 β-thalassemia and 7 of 46 controls. Anti-parvovirus B19 IgM antibodies were detected only in 4 of the sickle-cell anemia patients: two siblings and two unrelated who presented with acute erythroblastopenia at the time of blood collection for this study and had no history of past transfusion. B19 DNA was detected only in sera of these four patients and the corresponding 288 bp nested DNA amplicons were sequenced. The sequences obtained were all identical and phylogenetic analysis showed that they belonged to a new B19 virus strain of Genotype1.</p> <p>Conclusion</p> <p>A new parvovirus B19 strain of genotype1 was detected in four Tunisian patients with sickle-cell anemia. Virus transmission appeared to be nosocomial and resulted in acute erythroblastopenia in the four patients. The possibility of independent transmission of this B19 variant to the patients is unlikely in light of the present epidemiological data. However this possibility cannot be ruled out because of the low genetic variability of the virus.</p> |
| first_indexed | 2024-04-12T20:57:45Z |
| format | Article |
| id | doaj.art-28f94c4932e946168ebe5bcbc6c73e90 |
| institution | Directory Open Access Journal |
| issn | 1471-2334 |
| language | English |
| last_indexed | 2024-04-12T20:57:45Z |
| publishDate | 2007-10-01 |
| publisher | BMC |
| record_format | Article |
| series | BMC Infectious Diseases |
| spelling | doaj.art-28f94c4932e946168ebe5bcbc6c73e902022-12-22T03:16:56ZengBMCBMC Infectious Diseases1471-23342007-10-017112310.1186/1471-2334-7-123Parvovirus B19 infection in Tunisian patients with sickle-cell anemia and acute erythroblastopeniaZili MohamedKaroui MongiBejaoui MohamedOussaief LassadRegaya FaouziKhelifa Ridha<p>Abstract</p> <p>Background</p> <p>Human parvovirus B19 is the etiologic agent of erythema infectiosum in children. It is also associated with other clinical manifestations in different target groups. Patients with chronic hemolytic anemia are at high risk of developing acute erythroblastopenia following infection by the virus. They usually become highly viremic and pose an increased risk of virus transmission. Close monitoring of such high risk groups is required for epidemiologic surveillance and disease prevention activities. Here we report a molecular epidemiological study on B19 virus infection in Tunisian patients with chronic hemolytic anemia.</p> <p>Methods</p> <p>This study was conducted on 92 young chronic hemolytic anemia patients who attended the same ward at the National Bone Marrow Transplantation Center of Tunis and 46 controls from a different hospital. Screening for IgM and IgG anti-B19 antibodies was performed using commercially available enzyme immunoassays and B19 DNA was detected by nested PCR in the overlapping <it>VP1/VP2 </it>region. DNA was sequenced using dideoxy-terminator cycle sequencing technology.</p> <p>Results</p> <p>Anti-parvovirus B19 IgG antibodies were detected in 26 of 46 sickle-cell anemia patients, 18 of 46 β-thalassemia and 7 of 46 controls. Anti-parvovirus B19 IgM antibodies were detected only in 4 of the sickle-cell anemia patients: two siblings and two unrelated who presented with acute erythroblastopenia at the time of blood collection for this study and had no history of past transfusion. B19 DNA was detected only in sera of these four patients and the corresponding 288 bp nested DNA amplicons were sequenced. The sequences obtained were all identical and phylogenetic analysis showed that they belonged to a new B19 virus strain of Genotype1.</p> <p>Conclusion</p> <p>A new parvovirus B19 strain of genotype1 was detected in four Tunisian patients with sickle-cell anemia. Virus transmission appeared to be nosocomial and resulted in acute erythroblastopenia in the four patients. The possibility of independent transmission of this B19 variant to the patients is unlikely in light of the present epidemiological data. However this possibility cannot be ruled out because of the low genetic variability of the virus.</p>http://www.biomedcentral.com/1471-2334/7/123 |
| spellingShingle | Zili Mohamed Karoui Mongi Bejaoui Mohamed Oussaief Lassad Regaya Faouzi Khelifa Ridha Parvovirus B19 infection in Tunisian patients with sickle-cell anemia and acute erythroblastopenia BMC Infectious Diseases |
| title | Parvovirus B19 infection in Tunisian patients with sickle-cell anemia and acute erythroblastopenia |
| title_full | Parvovirus B19 infection in Tunisian patients with sickle-cell anemia and acute erythroblastopenia |
| title_fullStr | Parvovirus B19 infection in Tunisian patients with sickle-cell anemia and acute erythroblastopenia |
| title_full_unstemmed | Parvovirus B19 infection in Tunisian patients with sickle-cell anemia and acute erythroblastopenia |
| title_short | Parvovirus B19 infection in Tunisian patients with sickle-cell anemia and acute erythroblastopenia |
| title_sort | parvovirus b19 infection in tunisian patients with sickle cell anemia and acute erythroblastopenia |
| url | http://www.biomedcentral.com/1471-2334/7/123 |
| work_keys_str_mv | AT zilimohamed parvovirusb19infectionintunisianpatientswithsicklecellanemiaandacuteerythroblastopenia AT karouimongi parvovirusb19infectionintunisianpatientswithsicklecellanemiaandacuteerythroblastopenia AT bejaouimohamed parvovirusb19infectionintunisianpatientswithsicklecellanemiaandacuteerythroblastopenia AT oussaieflassad parvovirusb19infectionintunisianpatientswithsicklecellanemiaandacuteerythroblastopenia AT regayafaouzi parvovirusb19infectionintunisianpatientswithsicklecellanemiaandacuteerythroblastopenia AT khelifaridha parvovirusb19infectionintunisianpatientswithsicklecellanemiaandacuteerythroblastopenia |